C. M. Rive, J. Bourke, and E. J. Phillips, Testing for drug hypersensitivity syndromes, Clin Biochem Rev, vol.34, issue.1, pp.15-38, 2013.

M. Picard and M. C. Castells, Re-visiting hypersensitivity reactions to taxanes: a comprehensive review, Clin Rev Allergy Immunol, vol.49, issue.2, pp.177-191, 2015.

M. C. Castells, N. M. Tennant, and D. E. Sloane, Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases, J Allergy Clin Immunol, vol.122, issue.3, pp.574-580, 2008.

C. Guitart and M. C. , Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century, J Investig Allergol Clin Immunol, vol.24, issue.2, p.9, 2014.

M. Castells, S. Mdel, C. Simarro, and M. , Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization, Cancer Immunol Immunother, vol.61, issue.9, pp.1575-1584, 2012.

N. Makrilia, E. Syrigou, I. Kaklamanos, L. Manolopoulos, and M. W. Saif, Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review, Met Based Drugs, 2010.

P. G. Rose, N. Fusco, M. Smrekar, K. Mossbruger, M. Rodriguez et al., Successful administration of carboplatin in patients with

, clinically documented carboplatin hypersensitivity. Gynecol Oncol, vol.89, issue.3, pp.429-433, 2003.

D. Hamdan, C. Leboeuf, and C. Pereira, A digestive allergic reaction with hypereosinophilia imputable to docetaxel in a breast cancer patient: a case report, BMC Cancer, vol.15, p.993, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01397050

C. A. Naranjo, U. Busto, and E. M. Sellers, A method for estimating the probability of adverse drug reactions, Clin Pharmacol Ther, vol.30, issue.2, pp.239-245, 1981.

Y. Arimone, I. Bidault, and J. Dutertre, Updating the French method for the causality assessment of adverse drug reactions, Therapie, vol.68, issue.2, pp.69-76, 2013.

P. Demoly, A. Nf, and K. Brockow, International consensus on drug allergy, Allergy, vol.69, issue.4, pp.420-437, 2014.

E. Tomiak, P. Mj, and J. Kerger, Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis, J Clin Oncol, vol.12, issue.7, pp.1458-1467, 1994.

H. Rosing, V. Lustig, and L. Van-warmerdam, Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion, Cancer Chemother Pharmacol, vol.45, issue.3, pp.213-218, 2000.

V. Lm, B. Wallaert, and P. Desreumaux, Interleukin-5 immunoreactivity and mRNA expression in gut mucosa from patients with food allergy, Clin Exp Allergy, vol.29, issue.5, pp.652-659, 1999.

T. Shankar and A. A. Petrov, Omalizumab and hypersensitivity reactions, Curr Opin Allergy Clin Immunol, vol.13, issue.1, pp.19-24, 2013.